PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsYoichi Nagata, Dihua Yu, Xiaoyan Zhou et al.|Cancer Cell|2004Cited by 1.9k
Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphomaWenli Cui, Xiaoyan Zhou|Journal of Translational Medicine|2014Cited by 44